Bharat Biotech

Bharat Biotech’s COVAXIN® Authorized for Emergency Use by the World Health Organization

Emergency Use Listing by WHO will expedite global access and availability of COVAXIN® worldwide. The WHO's Emergency Use Listing (EUL) for…

3 years ago

Bharat Biotech Announces Phase 3 Results of COVAXIN®: India’s First COVID-19 Vaccine Demonstrates Interim Clinical Efficacy of 81%

Data from 25,800 participants, received vaccine or placebo in a 1:1 ratio showed that the vaccine candidate was well tolerated.…

4 years ago

North America to Dominate Coronavirus Vaccine Market through 2025 – TechSci Research

New Delhi, May 06, 2020: Growing cases of COVID-19 disease across the globe to drive the growth of global coronavirus vaccine…

5 years ago